Senesco Technologies, Inc. (SNT) Announces Results of Cohort 2 of its SNS01-T Phase 1b/2a Trial
6/19/2013 9:56:26 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (OTC QB: SNTI) reported results of cohort 2 in its Phase 1b/2a clinical study of SNS01-T.
Help employers find you! Check out all the jobs and post your resume.
comments powered by